Mv. Blagosklonny et Ws. Eldeiry, ACUTE OVEREXPRESSION OF WT P53 FACILITATES ANTICANCER DRUG-INDUCED DEATH OF CANCER AND NORMAL-CELLS, International journal of cancer, 75(6), 1998, pp. 933-940
The relationship between chemosensitivity and p53 is currently conside
red from two mutually exclusive points of view: (1) wt p53 increases c
hemosensitivity due to apoptosis and (2) wt p53 decreases chemosensiti
vity due to growth arrest and DNA repair. We used p53-expressing adeno
virus (Ad-p53) to directly evaluate effect of p53 on sensitivity to an
ticancer drugs. When p53 was expressed at sublethal levels, it sensiti
zed cells to the DNA-damaging drugs Adriamycin, mitomycin C, actinomyc
in D, etoposide (VP16), cisplatin and CPT11. This sensitization was ob
served in cancer cell lines (N = 10) regardless of endogenous p53 stat
us and also in normal human lung and skin fibroblasts. The degree of s
ensitization appeared to be greater in cancer cells with mutant p53. N
ormal fibroblasts required significantly higher doses of Ad-p53 to aff
ect a drug's sensitivity partly because of their lower infectivity by
adenovirus. Wt p53 not only decreased IC50 but also accelerated cell d
eath induced by DNA-damaging drugs. In contrast, sensitization to micr
otubule-active drugs by p53 was shown only in a few cell lines. We con
clude that exogenous wt p53 accelerates cell death induced by DNA dama
ging agents in both normal and cancer cells and offers no protection f
rom anticancer drugs. (C) 1998 Wiley-Liss, Inc.